The antiinfective medicine market in Belgium shows a consistent upward trajectory from 2024 to 2028, reflecting a steady demand in this segment. In 2023, the market stood at $940 million US Dollars PPP. The year-on-year growth rates reveal a moderate yet stable increase of approximately 1.7% to 2%, observed from 2024 to 2028. More specifically, the CAGR over the next five years is approximately 1.7%, indicating a smooth and gradual rise.
Key future trends to watch for include:
- Expansion in the development of advanced antiinfective drugs.
- Increasing healthcare expenditure and governmental policies supporting health innovation.
- Emerging resistance patterns prompting a shift in demand for more potent antiinfectives.
- Strategic alliances and mergers among pharmaceutical companies to enhance research and development capabilities.
